Lennox-Gastaut syndrome (LGS) is a rare epilepsy syndrome associated
with severe seizures in childhood. The syndrome usually begins during
infancy or early childhood and is characterized by uncontrollable
movements of the body. Those with LGS often have a resistance to
anti-seizure medications, leading to limited availability of treatment
options.
Dravet syndrome (DS) is a rare epilepsy syndrome most commonly caused by
a genetic mutation. The syndrome usually begins during infancy or
early childhood and is characterized by prolonged focal seizures that
can evolve into other seizure types. Those with DS often have a
resistance to anti-seizure medications, leading to limited availability
of treatment options.
This form is for data collection purposes only, to be
used to encourage clinical trials to come to the South Asian countries.
This information will remain private, and never shared without prior
consent. Only patient de-identified information will be shared with
pharmaceutical companies to understand patient demographics.
Participation in this database is important as it will help get
pharmaceutical companies sooner. Participation in this questionnaire is voluntary.
For any questions, please reach out to:
support@cdkl5southasia.com.